
1. Viruses. 2021 Oct 29;13(11). pii: 2182. doi: 10.3390/v13112182.

The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical
Impact in Mexico City.

Cedro-Tanda A(1), Gómez-Romero L(1), Alcaraz N(1), de Anda-Jauregui G(1)(2),
Peñaloza F(1), Moreno B(1), Escobar-Arrazola MA(3), Ramirez-Vega OA(3),
Munguia-Garza P(3), Garcia-Cardenas F(1), Cisneros-Villanueva M(1),
Moreno-Camacho JL(4), Rodriguez-Gallegos J(4)(5), Luna-Ruiz Esparza MA(6),
Fernández Rojas MA(6), Mendoza-Vargas A(1), Reyes-Grajeda JP(1), Campos-Romero
A(6), Angulo O(7), Ruiz R(7), Sheinbaum-Pardo C(8), Sifuentes-Osornio J(9),
Kershenobich D(9), Hidalgo-Miranda A(1), Herrera LA(1)(3).

Author information: 
(1)Instituto Nacional de Medicina Genómica, INMEGEN, Periferico Sur 4809, Arenal 
Tepepan, Tlalpan, Mexico City 14610, Mexico.
(2)Cátedras CONACYT para Jóvenes Investigadores, CONACYT, Av. de los Insurgentes 
Sur 1582, Crédito Constructor, Benito Juárez, Mexico City 03940, Mexico.
(3)Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de
Cancerología-Instituto de Investigaciones Biomédicas, UNAM, Av. San Fernando 22, 
Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico.
(4)Clinical Laboratory Division, Salud Digna, Culiacan, Sinaloa 80000, Mexico.
(5)Molecular Biology Laboratory, National Reference Center, Salud Digna,
Tlalnepantla de Baz, Estado de Mexico 54075, Mexico.
(6)Innovation and Research Department, Salud Digna, Culiacan, Sinaloa 80000,
Mexico.
(7)Secretaría de Educación, Ciencia, Tecnología e Innovacion, Av Chapultepec 49, 
Colonia Centro, Cuauhtémoc, Mexico City 06010, Mexico.
(8)Gobierno de la Ciudad de México, Antiguo Palacio del Ayuntamiento, Avenida
Plaza de la Constitución 2, Colonia Centro, Mexico City 06010, Mexico.
(9)Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de 
Quiroga 15, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico.

The SARS-CoV-2 pandemic is one of the most concerning health problems around the 
globe. We reported the emergence of SARS-CoV-2 variant B.1.1.519 in Mexico City. 
We reported the effective reproduction number (Rt) of B.1.1.519 and presented
evidence of its geographical origin based on phylogenetic analysis. We also
studied its evolution via haplotype analysis and identified the most recurrent
haplotypes. Finally, we studied the clinical impact of B.1.1.519. The B.1.1.519
variant was predominant between November 2020 and May 2021, reaching 90% of all
cases sequenced in February 2021. It is characterized by three amino acid changes
in the spike protein: T478K, P681H, and T732A. Its Rt varies between 0.5 and 2.9.
Its geographical origin remain to be investigated. Patients infected with variant
B.1.1.519 showed a highly significant adjusted odds ratio (aOR) increase of 1.85 
over non-B.1.1.519 patients for developing a severe/critical outcome (p =
0.000296, 1.33-2.6 95% CI) and a 2.35-fold increase for hospitalization (p =
0.005, 1.32-4.34 95% CI). The continuous monitoring of this and other variants
will be required to control the ongoing pandemic as it evolves.

DOI: 10.3390/v13112182 
PMCID: PMC8617872
PMID: 34834987 

